Effect of Kanglaite on palliative care in patients with advanced lung cancer
RONG Xiu-mei1 WANG Su1 LI Dong-yun2
1.Department of Oncology,Zhongguancun Hospital of Beijing City,Beijing 100190,China;
2.Department of Hematoloyoncology,Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine,Beijing 100700,China
Abstract:Objective To explore the effect of Kanglaite Injection on physical ability,cancer pain,traditional Chinese medicine symptoms,mental symptom of patients with advanced lung cancer,to evaluate its role in palliative care of advanced lung cancer.Methods 101 patients with advanced lung cancer were selected from August 2014 to May 2017 in Zhongguancun Hospital,which were divided into the observation group (49 cases)and the control group (52 cases)according to different treatment methods.Patients in control group were given supportive treatments only,and the observation group was given Kanglaite Injection for two cycles on the basis of the control group.The therapeutic effects of the two groups were compared.Results The score of Karnofsky and pain score in the observation group was better than that in the control group,with significant difference (P<0.05).After treatment,the scores of traditional Chinese medicine symptoms,scores of anxiety and depression in the observation group was lower than that in the control group,with significant difference(P<0.05).There was no significant difference in the incidence rate of adverse reactions between the two groups(P>0.05).Conclusion Kanglaite Injection plays an important role in palliative care,and it can improve life quality of advanced lung patient.
荣秀梅;王甦;李冬云. 康莱特在晚期肺癌缓和医疗中的作用[J]. 中国当代医药, 2017, 24(27): 86-88.
RONG Xiu-mei;WANG Su;LI Dong-yun. Effect of Kanglaite on palliative care in patients with advanced lung cancer. 中国当代医药, 2017, 24(27): 86-88.
Fernández-López C,Expósito-Hernández J,Arrebola-Moreno JP,et al.Trends in phase Ⅲ randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer[J].Cancer Med,2016,5(9):2190-2197.
[2]
YangSC,LaiWW,Hsiue TR,et al.Health-related quality of life after first-line anti-cancer treatments for advanced nonsmall cell lung cancer in Szu-Chun Yang[J].Qual Life Res,2016,25(6):1441-1449.
[3]
Guijarro-Mumoz I,Roarty EB,Heymach JV.Bevacizumab beyond disease progression for advanced non-small cell lung cancer:does persistence have its rewards?[J].Cancer,2016,122:1047-1049.
King JD,Eickhoff J,Traynor A,et al.Integrated onco-palliative care associated with prolonged survival compared to standard care for patients with advanced lung cancer:a retrospective review[J].J Pain Symptom Manage,2016,51(6):1027-1032.